PI3K (p110-alpha/p55-gamma), actif, son humain étiqueté, PRECISIO, recombinant, exprimé en cellules baculovirus infectées par Sf9, >=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5319-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PI3K (p110alpha/p55gamma) or Phosphatidylinositol 3-kinase is a lipid kinase that phosphorylates the inositol ring of phosphatidylinositol at the 3-prime ...


en savoir plus

Votre prix
£436.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PI3K (p110alpha/p55gamma) or Phosphatidylinositol 3-kinase is a lipid kinase that phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position which serve as second messengers in growth signaling pathways. PI3K comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in the PI3K has been associated with insulin resistance and plays an important role in glucose homeostasis in vivo. PI3K also plays an essential role in the development and induction of mast cells in normal and pathogenic immune responses.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... PIK3CA(5290)
mol wt~61 kDa (p85γ), ~111 kDa (p110α)
NCBI accession no.NM_006218
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity11.2-16.8 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: